Showing 8,294 results

Filters Content type: News, Editors' picks Country: Sub-Saharan Africa
New & experimental hepatitis C treatment

ALS-2200 (VX-135), Vertex's Oral Nucleotide Analogue in Development for Hepatitis C

Editor's pick
Vertex press release
11 November 2012
Cancer

The connection between Fatty Liver Disease and the Increase in the Rate of Liver Cancer

Editor's pick
AASLD press release
11 November 2012
New & experimental hepatitis C treatment

Twice-Daily Telaprevir Achieved Viral Cure (SVR12) Rates Similar to Those Treated Three Times Daily

Editor's pick
Vertex press release
11 November 2012
New & experimental hepatitis C treatment

Idenix Reports On IDX719 and IDX184

Editor's pick
Idenix press release
11 November 2012
Bad science & bogus treatments

Sowetan runs unethical ad

Editor's pick
JournAIDS
9 November 2012
Improving HIV care

South Africa: Private Sector Funding to Train Doctors

Editor's pick
AllAfrica
9 November 2012
Diabetes

D:A:D model is good predictor of diabetes in HIV-positive people

Editor's pick
International AIDS Society
9 November 2012
Condoms & lubricant

South African Breweries Condom Distribution to Taverns Averts More Than 20000 New HIV/AIDS Infections

Editor's pick
SAB Miller press release
8 November 2012
Side effects

Phase out D4T in poor countries

Editor's pick
Quackdown
7 November 2012
Epidemiology

Angola: Country to Keep HIV/Aids Prevalence Lower Than Three Per Cent Until 2015

Editor's pick
AllAfrica
7 November 2012
Men who have sex with men (MSM)

Very high HIV incidence among men who have sex with men in Kenya

News
7 November 2012
Circumcision

UGANDA: Mixed progress in male circumcision campaign

Editor's pick
IRIN Plus News
6 November 2012
Treatment outcomes & life expectancy

Death rates elevated at all CD4 counts below 500 in sub-Saharan Africa

News
6 November 2012
New & experimental hepatitis C treatment

Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012

Copy of Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012
Human rights

Malawi: Courageous Move to Suspend Anti-Gay Laws

Editor's pick
Human Rights Watch
6 November 2012

KENYA: Push to meet 2013 male circumcision targets

Editor's pick
IRIN
6 November 2012
Circumcision

KENYA: Push to meet 2013 male circumcision targets

Editor's pick
IRIN Plus News
6 November 2012

SOUTH AFRICA: Easy patents cost patients

Editor's pick
IRIN
6 November 2012
Access to healthcare

SOUTH AFRICA: Easy patents cost patients

Editor's pick
IRIN Plus News
6 November 2012
Malaria

Mozambique: Clear Connection Between HIV and Malaria Deaths

Editor's pick
AllAfrica
6 November 2012
Side effects

Tanzania: ARVs Safe to Use, Says Minister

Editor's pick
AllAfrica
6 November 2012
New & experimental hepatitis C treatment

Avoiding Missteps When Evaluating New HCV Trial Data

Editor's pick
Clinical Care Options (requires registration)
5 November 2012
Cancer

Cancer doctors pledge to take prevention and treatment to the poor

Editor's pick
The Guardian
5 November 2012